EMEA-002344-PIP02-18

Key facts

Active substance
liposomal ciclosporin A (L-CsA)
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0312/2019
PIP number
EMEA-002344-PIP02-18
Pharmaceutical form(s)
Powder for nebuliser solution
Condition(s) / indication(s)
Treatment of bronchiolitis obliterans syndrome
Route(s) of administration
Inhalation use
Contact for public enquiries
Breath Therapeutics GmbH

Tel.  +49 8990414910
E-mail: contact@breath-therapeutics.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating